Skip to main content

Published locations for Alemtuzumab plus CHOP didn’t boost survival in elderly patients with peripheral T-cell lymphomas

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Alemtuzumab plus CHOP didn’t boost survival in elderly patients with peripheral T-cell lymphomas

User login

  • Reset your password
  • /content/alemtuzumab-plus-chop-didnt-boost-survival-elderly-patients-peripheral-t-cell-lymphomas
  • /hematologynews/article/109556/t-cell-lymphomas/alemtuzumab-plus-chop-didnt-boost-survival-elderly
  • /hematologynews/nhlhub/article/109556/t-cell-lymphomas/alemtuzumab-plus-chop-didnt-boost-survival
  • /hematology-oncology/article/109556/t-cell-lymphomas/alemtuzumab-plus-chop-didnt-boost-survival